Girma Timsel, Alemu Wagaye, Assen Sofia
Department of Anesthesiology, Dilla University, Dilla, Ethiopia.
School of Public Health, Dilla University, Dilla, Ethiopia.
Front Med (Lausanne). 2022 Jul 28;9:887724. doi: 10.3389/fmed.2022.887724. eCollection 2022.
Shivering is the most common and unpleasant complication of anesthesia with an incidence of 70.7% in cesarean section done under spinal anesthesia which is associated with cardiovascular and respiratory complications. Even though it causes such devastating complications; the prevention of shivering is not well investigated. This study aimed to assess the effect of intrathecal pethidine on the incidence and severity of shivering in patients undergoing cesarean section under Spinal anesthesia.
After obtaining ethical clearance double-blinded single centered a randomized controlled trial was conducted in a total of 86 pregnant mothers who were randomly allocated into two groups by computer-generated random number. Approximately 1 ml of 10 mg preservative-free pethidine was added to 12.5 mg of 0.5% bupivacaine for spinal anesthesia in the treatment group and 12.5 mg of 0.5% bupivacaine alone was given in the control group. Incidence and severity of shivering, as well as adverse effect was recorded intraoperatively, in post-anesthesia care unit (PACU) and ward. Independent sample -test, Mann-Whitney test and chi-square were used for analysis. A -value less than 0.05 was considered statistically significant.
Shivering was observed in 53.5 and 20.9% in the control and treatment groups, respectively, which was statistically significant with = 0.002. The risk of developing shivering was reduced by 61% in the treatment group with ( = 0.39 and of 0.205-0.745); the intensity of shivering was also higher in the control group than in the treatment group with = 0.004. Considering an adverse effect, the incidence of PONV was not significantly different between with > 0.05 while the incidence of pruritus was higher in the treatment group than the control group with = 0.003.
Adding 10 mg of preservative free pethidine intrathecally during spinal anesthesia is effective in reducing incidence and severity of shivering, without causing significant adverse effects on mother.
寒战是麻醉最常见且令人不适的并发症,在腰麻下行剖宫产手术时发生率为70.7%,与心血管及呼吸系统并发症相关。尽管它会引发此类严重并发症,但寒战的预防尚未得到充分研究。本研究旨在评估鞘内注射哌替啶对腰麻下行剖宫产手术患者寒战发生率及严重程度的影响。
在获得伦理批准后,进行了一项双盲单中心随机对照试验,共纳入86名孕妇,通过计算机生成随机数将她们随机分为两组。治疗组在用于腰麻的12.5mg 0.5%布比卡因中加入约1ml 10mg无防腐剂哌替啶,对照组仅给予12.5mg 0.5%布比卡因。术中、麻醉后护理单元(PACU)及病房记录寒战的发生率及严重程度以及不良反应。采用独立样本t检验、曼-惠特尼检验和卡方检验进行分析。P值小于0.05被认为具有统计学意义。
对照组和治疗组寒战发生率分别为53.5%和20.9%,差异有统计学意义(P = 0.002)。治疗组发生寒战的风险降低了61%(OR = 0.39,95%CI为0.205 - 0.745);对照组寒战强度也高于治疗组(P = 0.004)。考虑不良反应,两组恶心呕吐发生率差异无统计学意义(P > 0.05),而治疗组瘙痒发生率高于对照组(P = 0.003)。
腰麻时鞘内注射10mg无防腐剂哌替啶可有效降低寒战的发生率及严重程度,且对母亲无明显不良反应。